Neurocrine Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $1.31B
Liabilities Breakdown FY2019
Total Liabilities: $669.1M
Asset Breakdown
Total Assets: $1.31B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $112.3M | 8.6% |
| Accounts Receivable | $126.6M | 9.7% |
| Inventory | $17.3M | 1.3% |
| Property, Plant & Equipment | $41.9M | 3.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.01B | 77.2% |
Liabilities Breakdown
Total Liabilities: $669.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $669.1M | 100.0% |